Arteriosclerosis Occlusive Disease
Conditions
Interventions
Experimental group:Use 0% oversize
Control group:10%OVERSIZE
Sponsors
General Hospital of Tianjin Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Comply with surgical treatment of femoral popliteal arterial bypass potential patients TASC II class C occluded lesion; 2. Rutherford grades 2-5; 3. Male and non-pregnant female patients aged more than 18 years; 4. The target lesion inflow vessel has lesion, but the target lesion has been successfully treated before treatment; 5. ABI 0.7 or TBI 0.5; 6. Angiography: (1) at least one unobstructed distal outflow artery; (2) the lesion can be predilated; (3) the reference vessel diameter is between 4.0mm and 7.5mm (must be measured rather than estimated).
Exclusion criteria
Exclusion criteria: 1. Be not suitable for vascular interventional surgery treatment (PTCA) patients; 2. Pregnancy and lactation female patients; 3. An unmanageable disease of proximal arterial occlusion; 4. Lower limb aneurysm; 5. Rutherford class 5 above and with active infection; 6. Known coagulation disorder; 7. Patients with known allergy to heparin, aspirin, other anticoagulation and antiplatelet therapy, contrast agents; 8. Patients with a life expectancy of less than one year; 9. Patients have participated in clinical trials of other drugs or devices, and have not completed the main endpoint follow-up; 10. Strokes rounding out the top three months; 11. Happened for two weeks MI MI or angina pectoris; 12. Preoperative renal exhaustion or chronic renal disease serum creatinine 14 days Every 1.73 m2; Or people on dialysis; 13. Thread can't through the target lesion (success through the target lesion refers to the there is no current limiting sandwich or without perforation; The distal end of the guidewire can reach and pass through the target lesion; 14. People who are ill or don't want to participate in this trial.
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| The first patency rate of target lesions at 12 months after surgery; | — |
Countries
China
Contacts
Public ContactDai Xiang chen
General Hospital of Tianjin
Outcome results
None listed